butorphanol tartrate injection, USP Indications and Usage

INDICATIONS AND USAGE

Butorphanol Tartrate Injection is indicated

•
as a preoperative or pre-anesthetic medication
•
as a supplement to balanced anesthesia
•
for the relief of pain during labor, and
•
for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Limitations of Use:

Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see WARNINGS], reserve butorphanol tartrate for use in patients for whom alternative treatment options (e.g., non-opioid analgesics):

•
Have not been tolerated, or are not expected to be tolerated,
•
Have not provided adequate analgesia, or are not expected to provide adequate analgesia.

Butorphanol Tartrate Injection should not be used for an extended period of time unless the pain ‎remains severe enough to require an opioid analgesic and for which ‎alternative treatment options continue to be inadequate.‎

Find butorphanol tartrate injection, USP medical information:

Find butorphanol tartrate injection, USP medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

butorphanol tartrate injection, USP Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

Indications and Usage

INDICATIONS AND USAGE

Butorphanol Tartrate Injection is indicated

•
as a preoperative or pre-anesthetic medication
•
as a supplement to balanced anesthesia
•
for the relief of pain during labor, and
•
for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Limitations of Use:

Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see WARNINGS], reserve butorphanol tartrate for use in patients for whom alternative treatment options (e.g., non-opioid analgesics):

•
Have not been tolerated, or are not expected to be tolerated,
•
Have not provided adequate analgesia, or are not expected to provide adequate analgesia.

Butorphanol Tartrate Injection should not be used for an extended period of time unless the pain ‎remains severe enough to require an opioid analgesic and for which ‎alternative treatment options continue to be inadequate.‎

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.